Orforglipron, sold under the brand name Foundayo, is a new once-daily prescription pill for chronic weight management
Because semaglutide does not contain sulfa or sulfonamides, there is no direct chemical link between semaglutide and the drugs that typically cause sulfa allergies
The OASIS-1 trial, which studied adults with obesity and overweight taking a daily 50 mg oral semaglutide, found that participants experienced a 15.1% average reduction in body weight over 68 weeks
When to Seek Care While dietary adjustments can often help, it is crucial to recognize when symptoms like persistent fatigue or frequent illness could indicate deeper issues
With NAD+ therapy, the shift can be surprisingly noticeable
High-protein complete meal With 40g of protein and 173 health benefits per serving, this meal powder is the ultimate convenient meal when time is short